Michigan State University - Department of Radiology
East Lansing, Michigan, 48824, United States
Completed
NCT Number: NCT02335567
Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms
To compare two competing newly designed 3D sequences for black blood carotid plaque imaging techniques with the industry standard 2D sequnce for black blood.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–85 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
To utilize a 3D sequence instead of the usual 2D commonly standard industry sequence that is supplied by the various manufacturers.
Patients with greater than 50% stenosis that are 3T compatible are imaged using the two sequences to compare which sequences better visualize the plaque and it's characteristics
The purpose is to validate the ability of the new 3D sequence to detect and measure any plaque hemorrhage as well as to identify region sof Type 1 hemorrhage.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with 50% stenosis of the carotid arteries that are safe to undergo MRI imaging
Exclusion criteria
- Patients that are determined to no be safe to undergo MR imaging due to implants
Treatment and study plan
There is no intervention
OtherPrimary outcomes
-
Appearance of intraplaque hemorrhage
Time frame: 1 day of scan
what radiologist interperts
Sponsors and collaborators
Lead sponsor
Michigan State University
Other
Registry information
Acronym: 3TMR
Important dates
- Study start
- 2012
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jan 9, 2015
- Registry last updated
- Sep 16, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.